https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-01-29 / Curr. Opin. Immunol. 2010 Feb;22(1):137-44
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-01-29 / Curr. Opin. Immunol. 2010 Feb;22(1):137-442010-01-29 00:00:002019-02-15 08:44:07Presentation of tumour antigens by dendritic cells and challenges faced
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-01-25 / Oncogene 2010 Apr;29(15):2205-16
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-01-25 / Oncogene 2010 Apr;29(15):2205-162010-01-25 00:00:002019-02-15 09:21:49Rac1 is required for oncolytic NDV replication in human cancer cells and establishes a link between tumorigenesis and sensitivity to oncolytic virus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-01-06 / BMC Cancer 2010 Jan;10:5
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-01-06 / BMC Cancer 2010 Jan;10:52010-01-06 00:00:002019-02-15 08:43:59Tocotrienols are good adjuvants for developing cancer vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-01-01 / Int J Hyperthermia 2010;26(2):118-26
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-01-01 / Int J Hyperthermia 2010;26(2):118-262010-01-01 00:00:002010-01-01 00:00:00Regional abdominal hyperthermia combined with systemic chemotherapy for the treatment of patients with ovarian cancer relapse: Results of a pilot study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-01-01 / J. Virol. 2010 Jan;84(1):639-46
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-01-01 / J. Virol. 2010 Jan;84(1):639-462010-01-01 00:00:002010-01-01 00:00:00The oncolytic activity of Newcastle disease virus NDV-HUJ on chemoresistant primary melanoma cells is dependent on the proapoptotic activity of the inhibitor of apoptosis protein Livin
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-01-01 / Int J Hyperthermia 2010;26(2):108-17
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-01-01 / Int J Hyperthermia 2010;26(2):108-172010-01-01 00:00:002019-02-15 08:39:21Regional hyperthermia added to intensified preoperative chemo-radiation in locally advanced adenocarcinoma of middle and lower rectum
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-01-01 / Crit. Rev. Immunol. 2010;30(4):345-86
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-01-01 / Crit. Rev. Immunol. 2010;30(4):345-862010-01-01 00:00:002019-02-15 08:40:16Tumor antigen presentation by dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-01-01 / Hum. Immunol. 2010 Jan;71(1):67-73
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-01-01 / Hum. Immunol. 2010 Jan;71(1):67-732010-01-01 00:00:002019-02-15 08:44:09Identification of a microRNA signature in dendritic cell vaccines for cancer immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-01-01 / Methods Mol. Biol. 2010;595:149-63
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-01-01 / Methods Mol. Biol. 2010;595:149-632010-01-01 00:00:002019-02-15 08:44:11Towards a standardized protocol for the generation of monocyte-derived dendritic cell vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-01-01 / Immunotherapy 2010 Jan;2(1):57-68
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-01-01 / Immunotherapy 2010 Jan;2(1):57-682010-01-01 00:00:002019-02-15 08:45:16Personalized dendritic cell-based tumor immunotherapy
